Applying the chronic care model (CCM) for diabetes management helps improve health outcomes and patient care. The CCM was implemented at U.S. Air Force Wilford Hall Medical Center through the Diabetes Outreach Clinic (DOC) in 2006, but its cost-effectiveness in this setting is unknown.
Methods:
We constructed a Markov decision model to estimate DOC cost-effectiveness compared with usual care (UC) over a 20-year period. Based on empirical, post-intervention demographic and clinical data, we applied United Kingdom Prospective Diabetes Study risk equations to predict long-term probabilities of developing microvascular or macrovascular complications. Health care system and societal perspectives were considered, discounting costs and benefits at 3% annually. Intervention costs and outcomes were obtained from military data, while other costs, disease progression data, and utilities were drawn from published literature.
Results:
From a health care system perspective, the DOC cost $45,495 per quality-adjusted life-year (QALY) compared with UC; from a societal perspective, the DOC compared with UC cost $42,051/QALY (when the model started with the uncomplicated diabetes cohort), $61,243/QALY (when starting with the DOC cohort), or $61,813/QALY (when starting with the UC cohort). In one-way sensitivity analyses, results were most sensitive to yearly costs for specialty care visits. In probabilistic sensitivity analysis, the DOC was favored in 51% of model iterations using an acceptability threshold of $50,000/QALY and in 72% at a threshold of $100,000/QALY.
Conclusions:
The DOC strategy for diabetes care, performed with the CCM methodology in a military population, appears to be economically reasonable compared with UC.
Centers for Disease Control and Prevention. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
2.
ZhangPZhangXBrownJVistisenDSicreeRShawJNicholsG. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract.2010;87 (3): 293–301.
3.
DallTMZhangYChenYJQuickWWYangWGFogliJ. The economic burden of diabetes. Health Aff (Millwood).2010;29 (2): 297–303.
4.
DancerSCourtneyM. Improving diabetes patient outcomes: Framing research into the chronic care model. J Am Acad Nurse Pract.2010;22 (11): 580–5.
5.
American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care.2011;34Suppl 1: S11–61.
6.
NathanDMBuseJBDavidsonMBFerranniniEHolmanRRSherwinRZinmanB; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care.2009;32 (1): 193–203.
7.
DavidsonMB. The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: A narrative review. Curr Diabetes Rev.2007;3 (4): 280–6.
8.
ResnickHEFosterGLBardsleyJRatnerRE. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999–2002: The National Health and Nutrition Examination Survey. Diabetes Care.2006;29 (3): 531–7.
9.
CheungBMOngKLChernySSShamPCTsoAWLamKS. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med.2009;122 (5): 443–53.
10.
WagnerEH. Chronic disease management: What will it take to improve care for chronic illness?Eff Clin Pract.1998;1 (1): 2–4.
11.
WarmEJ. Diabetes and the chronic care model: A review. Curr Diabetes Rev.2007;3 (4): 219–25.
12.
SiDBailieRWeeramanthriT. Effectiveness of chronic care model-oriented interventions to improve quality of diabetes care: A systematic review. Prim Health Care Res Dev.2008;9 (1): 25–40.
13.
ColemanKMattkeSPerraultPJWagnerEH. Untangling practice redesign from disease management: How do we best care for the chronically ill?Annu Rev Public Health.2009;30: 385–408.
14.
ColemanKAustinBTBrachCWagnerEH. Evidence on the chronic care model in the new millennium. Health Aff (Millwood).2009;28 (1): 75–85.
15.
SiminerioLM. The role of technology and the chronic care model. J Diabetes Sci Technol.2010;4 (2): 470–5.
16.
WagnerEHGrothausLCSandhuNGalvinMSMcGregorMArtzKColemanEA. Chronic care clinics for diabetes in primary care: A system-wide randomized trial. Diabetes Care.2001;24 (4): 695–700.
17.
BodenheimerTWagnerEHGrumbachK. Improving primary care for patients with chronic illness. JAMA.2002;288 (14): 1775–9.
18.
BodenheimerTWagnerEHGrumbachK. Improving primary care for patients with chronic illness: The chronic care model, Part 2. JAMA.2002;288 (15): 1909–14.
19.
SiminerioLZgiborJSolanoFX. Implementing the chronic care model for improvements in diabetes practice and outcomes in primary care: The University of Pittsburgh Medical Center experience. Clin Diabetes.2004;22 (2): 54–8.
20.
SiminerioLMPiattGZgiborJC. Implementing the chronic care model for improvements in diabetes care and education in a rural primary care practice. Diabetes Educ.2005;31 (2): 225–34.
21.
SiminerioLMPiattGAEmersonSRuppertKSaulMSolanoFStewartAZgiborJC. Deploying the chronic care model to implement and sustain diabetes self-management training programs. Diabetes Educ.2006;32 (2): 253–60.
22.
AADESiminerioLMDrabSRGabbayRAGoldKMcLaughlinSPiattGASolowiejczykJWeilR. Diabetes educators: Implementing the chronic care model. Diabetes Educ.2008;34 (3): 451–6.
23.
PiattGAOrchardTJEmersonSSimmonsDSongerTJBrooksMMKorytkowskiMSiminerioLMAhmadUZgiborJC. Translating the chronic care model into the community: Results from a randomized controlled trial of a multifaceted diabetes care intervention. Diabetes Care.2006;29 (4): 811–7.
24.
PiattGAZgiborJC. Novel approaches to diabetes care: A population perspective. Curr Opin Endocrinol Diabetes Obes.2007;14 (2): 158–65.
25.
PiattGAAndersonRMBrooksMMSongerTSiminerioLMKorytkowskiMMZgiborJC. 3-year follow-up of clinical and behavioral improvements following a multifaceted diabetes care intervention: Results of a randomized controlled trial. Diabetes Educ.2010;36 (2): 301–9.
26.
ChinMHCookSDrumMLJinLGuillenMHumikowskiCAKoppertJHarrisonJFLippoldSSchaeferCT; Midwest cluster health disparities collaborative. Improving diabetes care in midwest community health centers with the health disparities collaborative. Diabetes Care.2004;27 (1): 2–8.
27.
LandonBEHicksLSO'MalleyAJLieuTAKeeganTMcNeilBJGuadagnoliE. Improving the management of chronic disease at community health centers. N Engl J Med.2007;356 (9): 921–34.
28.
ChinMHDrumMLGuillenMRimingtonALevieJRKirchhoffACQuinnMTSchaeferCT. Improving and sustaining diabetes care in community health centers with the health disparities collaboratives. Med Care.2007;45 (12): 1135–43.
29.
BattersbyMW. Health reform through coordinated care: SA HealthPlus. BMJ.2005;330 (7492): 662–5.
30.
OlivariusNFBeck-NielsenHAndreasenAHHørderMPedersenPA. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ.2001;323 (7319): 970–5.
31.
HissRGArmbrusterBAGillardMLMcClureLA. Nurse care manager collaboration with community-based physicians providing diabetes care: A randomized controlled trial. Diabetes Educ.2007;33 (3): 493–502.
32.
SmithSAShahNDBryantSCChristiansonTJBjornsenSSGieslerPDKrauseKErwinPJMontoriVM; Evidens Research Group. Chronic care model and shared care in diabetes: Randomized trial of an electronic decision support system. Mayo Clin Proc.2008;83 (7): 747–57.
33.
PetersonKARadosevichDMO'ConnorPJNymanJAPrineasRJSmithSAArnesonTJCorbettVAWeinhandlJCLangeCJHannanPJ. Improving diabetes care in practice: Findings from the TRANSLATE trial. Diabetes Care.2008;31 (12): 2238–43.
34.
HungDYGlasgowREDickinsonLMFroshaugDBFernaldDHBalasubramanianBAGreenLA. The chronic care model and relationships to patient health status and health-related quality of life. Am J Prev Med.2008;35 (5 Suppl): S398–406.
35.
SchillingerDHandleyMWangFHammerH. Effects of self-management support on structure, process, and outcomes among vulnerable patients with diabetes: A three-arm practical clinical trial. Diabetes Care.2009;32 (4): 559–66.
KressAMHartzelMCPetersonMR. Burden of disease associated with overweight and obesity among U.S. military retirees and their dependents, aged 38–64, 2003. Prev Med.2005;41 (1): 63–9.
38.
GibsonTBLeeTAVogeliCSHidalgoJCarlsGSSredlKDesHarnaisSMarderWDWeissKBWilliamsTVShieldsAE. A four-system comparison of patients with chronic illness: The Military Health System, Veterans Health Administration, Medicaid, and commercial plans. Mil Med.2009;174 (9): 936–43.
39.
BoykoEJJacobsonIGSmithBRyanMAHooperTIAmorosoPJGackstetterGDBarrett-ConnorESmithTC; Millennium Cohort Study Team. Risk of diabetes in U.S. military service members in relation to combat deployment and mental health. Diabetes Care.2010;33 (8): 1771–7.
40.
GorhamEDBarrett-ConnorEHighfill-McRoyRMMohrSBGarlandCFGarlandFCRicordiC. Incidence of insulin-requiring diabetes in the US military. Diabetologia.2009;52 (10): 2087–91.
41.
GreenburgDHaverkosHWVigerskyR. Diabetes mellitus, active component, U.S. Armed Forces, 1997–2007. Med Surveillance Monthly Rep.2009;16 (2): 7–9.
42.
Army Medical Surveillance Activity. Incidence of diabetes mellitus among active duty service members, U.S. Armed Forces, 1998. Med Surveillance Monthly Rep.1999;5: 7–9.
DallTMZhangYChenYJWagnerRCHoganPFFaganNKOlaiyaSTTornbergDN. Cost associated with being overweight and with obesity, high alcohol consumption, and tobacco use within the military health system's TRICARE prime-enrolled population. Am J Health Promot.2007;22 (2): 120–39.
45.
KuoSSmithKJZgiborJCPiattGARobertsMSBryceCL. Cost-effectiveness of implementing the chronic care model for diabetes care in the community. Presented at: 31st Annual Meeting of the Society for Medical Decision Making (October 18–21, 2009).
46.
GoldMRSiegelJERussellLBWeinsteinMC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
47.
U. S. Department of Labor; Bureau of Labor Statistics. Databases, tables, and calculators by subject. http://www.bls.gov/data/. Accessed January 31, 2011.
48.
ColemanRLStevensRJAldingtonSJHolmanRR. Estimating risk of clinically evident retinopathy in type 2 diabetes. Diabetes.2006;55Suppl 1: A53.
49.
ColemanRLStevensRJHolmanRR. Estimating risk of clinically evident neuropathy in type 2 diabetes: A UKPDS risk equation. Diabet Med.2006;23Suppl 2: 51.
50.
ColemanRLStevensRJHolmanRR. Incident nephropathy in type 2 diabetes: A UKPDS risk equation. Diabetologia.2005;48Suppl 1: A32.
51.
StevensRJKothariVAdlerAIStrattonIM; United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: A model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond).2001;101 (6): 671–9.
52.
KothariVStevensRJAdlerAIStrattonIMManleySENeilHAHolmanRR. UKPDS 60: Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke.2002;33 (7): 1776–81.
53.
StevensRJColemanRLAdlerAIStrattonIMMatthewsDRHolmanRR. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care.2004;27 (1): 201–7.
54.
ZoungasSde GalanBENinomiyaTGrobbeeDHametPHellerSMacMahonSMarreMNealBPatelAWoodwardMChalmersJ; ADVANCE Collaborative Group, CassAGlasziouPHarrapSLishengLManciaGPillaiAPoulterNPerkovicVTravertF. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care.2009;32 (11): 2068–74.
55.
U. S. Department of Health and Human Services; Centers for Medicare and Medicaid Services. Medicare fee-for-service payment. http://www.cms.hhs.gov/home/medicare.asp. Accessed January 31, 2011.
56.
CDC Diabetes Cost-Effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA.2002;287 (19): 2542–51.
57.
SmithKJCookRLNessRB. Cost comparisons between home-and clinic-based testing for sexually transmitted diseases in high-risk young women. Infect Dis Obstet Gynecol.2007;2007: 62467.
58.
CoffeyJTBrandleMZhouHMarriottDBurkeRTabaeiBPEngelgauMMKaplanRMHermanWH. Valuing health-related quality of life in diabetes. Diabetes Care.2002;25 (12): 2238–43.
59.
DoubiletPBeggCBWeinsteinMCBraunPMcNeilBJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making.1985;5 (2): 157–77.
60.
LöthgrenMZethraeusN. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ.2000;9 (7): 623–30.
61.
StinnettAAMullahyJ. Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making.1998;18 (2 Suppl): S68–80.
62.
DrummondMFSculpherMJTorranceGWO'BrienBJStoddartGL. Methods for the economic evaluation of health care programmes. 3rd ed.New York: Oxford University Press; 2005.
63.
HuangESZhangQBrownSEDrumMLMeltzerDOChinMH. The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers. Health Serv Res.2007;42 (6 Pt 1): 2174–93.
64.
UbelPAHirthRAChernewMEFendrickAM. What is the price of life and why doesn't it increase at the rate of inflation?Arch Intern Med.2003;163 (14): 1637–41.
65.
HermanWHHoergerTJBrandleMHicksKSorensenSZhangPHammanRFAckermannRTEngelgauMMRatnerRE; Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med.2005;142 (5): 323–32.
66.
BraithwaiteRSMeltzerDOKingJTJrLeslieDRobertsMS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?Med Care.2008;46 (4): 349–56.
67.
OwensDKQaseemAChouRShekelleP; Clinical Guidelines Committee of the American College of Physicians. High-value, cost-conscious health care: Concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med.2011;154 (3): 174–80.
68.
GusmanoMKCallahanD. “Value for money”: Use with care. Ann Intern Med.2011;154 (3): 207–8.
